Feature Channels: Respiratory Diseases and Disorders

Filters close
1-Mar-2021 9:00 AM EST
Vaping marijuana associated with more symptoms of lung damage than vaping or smoking nicotine
University of Michigan

Adolescents who vape cannabis are at greater risk for respiratory symptoms indicative of lung injury than teens who smoke cigarettes or marijuana, or vape nicotine, a new University of Michigan study suggests.

3-Mar-2021 10:00 AM EST
ACTG to Present 24 New Studies at CROI 2021
University of California, Los Angeles (UCLA), Health Sciences

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, will present four oral and 20 scientific spotlight sessions at the Conference on Retroviruses and Opportunistic Infections (CROI 2021) held virtually, March 6-10.

Released: 3-Mar-2021 9:00 AM EST
Same Surgeon, Different Light: Dr. Shanda Blackmon
The Society of Thoracic Surgeons

In this episode, Dr. Tom Varghese interviews Dr. Shanda Blackmon from the Mayo Clinic.

Released: 3-Mar-2021 8:00 AM EST
Same Surgeon, Different Light: Dr. Tom Varghese
The Society of Thoracic Surgeons

In this episode, Dr. David Tom Cooke interviews Dr. Tom Varghese from the University of Utah. Dr. Varghese shares captivating details of his “very unique life.”

Released: 2-Mar-2021 9:45 AM EST
CHOP Researchers Find Effective Combination of Therapies for Managing Mitochondrial Disease
Children's Hospital of Philadelphia

Researchers have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders. This preclinical research paves the way to develop more tailored treatment options for patients with inherited mitochondrial disease and acquired energy disorders.

Released: 2-Mar-2021 9:00 AM EST
Same Surgeon, Different Light: Dr. David Tom Cooke
The Society of Thoracic Surgeons

In this episode, Dr. Tom Varghese interviews Dr. David Tom Cooke from UC Davis Health.

Released: 2-Mar-2021 8:00 AM EST
Same Surgeon, Different Light: Dr. Leah Backhus
The Society of Thoracic Surgeons

In this episode, Dr. David Tom Cooke interviews STS Director-at-Large Dr. Leah Backhus from Stanford Health Care.

Released: 1-Mar-2021 9:00 AM EST
Same Surgeon, Different Light: Dr. Doug Mathisen
The Society of Thoracic Surgeons

In this episode, Dr. Tom Varghese interviews Dr. Doug Mathisen, STS Historian and Past President.

Released: 1-Mar-2021 8:00 AM EST
Same Surgeon, Different Light: Dr. Joanna Chikwe
The Society of Thoracic Surgeons

In this episode, Dr. David Tom Cooke interviews Dr. Joanna Chikwe, chair of the Cardiac Surgery Department in the Smidt Heart Institute at Cedars-Sinai.

Released: 1-Mar-2021 8:00 AM EST
Paper Addresses Research Needed to Understand Smoking and COVID-19 Risk
American Thoracic Society (ATS)

A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.

Released: 26-Feb-2021 8:00 AM EST
Same Surgeon, Different Light: Dr. Richard Prager
The Society of Thoracic Surgeons

In this episode, Dr. David Tom Cooke interviews Dr. Richard Prager, STS Past President and director of the Frankel Cardiovascular Center at the University of Michigan.

Released: 25-Feb-2021 2:15 PM EST
UIC researchers find new biomarker for active sarcoidosis
University of Illinois Chicago

Low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis — an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes — which disproportionately affects African Americans. The discovery by researchers at the University of Illinois Chicago could help guide disease treatment.

Released: 25-Feb-2021 11:20 AM EST
Same Surgeon, Different Light: Dr. Robert Higgins
The Society of Thoracic Surgeons

In this inaugural episode, Dr. Tom Varghese interviews Dr. Robert Higgins, STS Past President and surgeon-in-chief at The Johns Hopkins Hospital.

Released: 24-Feb-2021 2:55 PM EST
Abnormal sodium levels in hospitalized patients with COVID-19 predict death or respiratory failure
Endocrine Society

Hospitalized patients with COVID-19 and abnormal sodium levels in the blood have an increased risk of experiencing respiratory failure or dying, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released: 24-Feb-2021 2:05 PM EST
Hackensack Meridian Hackensack University Medical Center First Hospital in the World to Use Innovative ECMO Technology to Treat Patient with COVID-19
Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center has become the first hospital in the world to use a new extracorporeal membrane oxygenation (ECMO) system to treat and improve breathing for a patient with COVID-19.

   
Released: 23-Feb-2021 2:30 PM EST
New strategy blocks chronic lung disease in mice
Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis has uncovered a previously unknown role for exosomes in inflammatory respiratory diseases. The study has implications for finding new therapies. Exosomes are tiny compartments released from cells that carry different types of cargo, including inflammatory chemicals called cytokines that can drive lung disease.

22-Feb-2021 7:00 AM EST
How Reducing Body Temperature Could Help a Tenth of All ICU Patients
Biophysical Society

ROCKVILLE, MD – A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS).

   
Released: 22-Feb-2021 4:40 PM EST
How outdoor pollution affects indoor air quality
University of Utah

In a long-term study in a Salt Lake-area building, researchers found that the amount of air pollution that comes indoors depends on the type of outdoor pollution. Wildfires, fireworks and wintertime inversions all affect indoor air to different degrees.

18-Feb-2021 10:25 AM EST
Scientists launch a pre-emptive strike on deadly post-transplant infection
University of Cambridge

Around 80% of the UK population is currently infected with human cytomegalovirus (HCMV) and in developing countries this can be as high as 95%.

Released: 22-Feb-2021 9:00 AM EST
Learn the Symptoms of Pulmonary Fibrosis this Rare Disease Day
Pulmonary Fibrosis Foundation

To mark Rare Disease Day on February 28, the Pulmonary Fibrosis Foundation (PFF) aims to increase public understanding of pulmonary fibrosis (PF) to drive home the importance of early diagnosis to help improve the quality of life for patients.

Released: 17-Feb-2021 8:00 AM EST
Save the Date! Dr. Anthony Fauci to Open ATS 2021 International Conference
American Thoracic Society (ATS)

The ATS 2021 International Conference is May 14-19 this year. We’re virtual and, therefore, available anywhere you are. Our featured speaker is Dr. Anthony Fauci, who will present at the opening ceremony on Saturday, May 15.

Released: 15-Feb-2021 11:50 AM EST
Researchers propose that humidity from masks may lessen severity of COVID-19
NIH, National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK)

Masks help protect the people wearing them from getting or spreading SARS-CoV-2, the virus that causes COVID-19, but now researchers from the National Institutes of Health have added evidence for yet another potential benefit for wearers: The humidity created inside the mask may help combat respiratory diseases such as COVID-19.

Released: 15-Feb-2021 8:00 AM EST
TB study reveals potential targets to treat and control infection using cutting-edge technology
Texas Biomedical Research Institute

Researchers at the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) may have found a new pathway to treat and control tuberculosis (TB), the disease caused by Mycobacterium tuberculosis (Mtb). Using single-cell RNA sequencing (scRNAseq), a next-generation sequencing technology, scientists were able to further define the mechanisms that lead to TB infection and latency.

   
Released: 10-Feb-2021 4:00 PM EST
Investigating the Long-term Effects of COVID-19
Thomas Jefferson University

Jefferson researchers join a CDC study to follow COVID-19 “long-haulers” and their symptoms.

Released: 10-Feb-2021 8:00 AM EST
Chocolate-flavored E-cigarettes Are Most Harmful to Your Airways
American Physiological Society (APS)

New research shows chocolate-flavored e-cigarettes are “particularly harmful” to the lungs.

   
Released: 9-Feb-2021 1:50 PM EST
Can Current Smartphone Technology Tell You When a Pandemic Might Come Calling?
UC San Diego Health

UC San Diego researchers find that an optical tool already embedded in many smartphones can accurately diagnose blood-oxygen levels and help monitor respiratory disease in patients, particularly when they are quarantined at home.

   
Released: 2-Feb-2021 3:00 PM EST
The Contagion Year
Harvard Medical School

Experts discuss key insights in clinical treatment of COVID-19 from Year One of the pandemic.

1-Feb-2021 12:40 PM EST
Study finds recommended ICU sedatives equally safe, effective
Vanderbilt University Medical Center

A study published today in the New England Journal of Medicine provides the most definitive evidence to date that, of the two drugs recommended for light sedation of patients receiving mechanical ventilation in the ICU, one is as effective and safe as the other.

Released: 1-Feb-2021 4:05 PM EST
Rush Respiratory Care Team Honored for its Impact
RUSH

Recently awarded two APEX Recognition Awards, respiratory therapists at Rush are advancing COVID-19 treatment.

Released: 1-Feb-2021 11:10 AM EST
NIH study shows hyaluronan is effective in treating chronic lung disease
National Institute of Environmental Health Sciences (NIEHS)

NIH researchers and their collaborators found that inhaling unfragmented hyaluronan improves lung function in patients suffering from severe exacerbation of COPD. Hyaluronan is a sugar secreted by living tissue that acts as a scaffold for cells. Utilized as a treatment, hyaluronan decreased the number of days in the hospital.

   
25-Jan-2021 12:50 PM EST
Iron-Carrying Extracellular Vesicles are Key to Respiratory Viral-Bacterial Coinfection
Health Sciences at the University of Pittsburgh

The finding can offer a new way for creating therapies to prevent secondary bacterial infections.

Released: 26-Jan-2021 9:40 AM EST
Hospital worker flu shots could mean fewer deaths
University of Georgia

Research from the University of Georgia shows that state laws promoting flu vaccinations for hospital workers can substantially reduce the number of influenza-related deaths.

Released: 26-Jan-2021 9:00 AM EST
Smokers – you’re at risk for this disease
Pulmonary Fibrosis Foundation

According to the Surgeon General, 14% of Americans smoke and 16 million suffer from smoking-related diseases. Pulmonary fibrosis, a debilitating disease often caused by tobacco usage, is little-known among smokers. The Pulmonary Fibrosis Foundation shares insights on critical risk factors.

Released: 21-Jan-2021 7:00 PM EST
New immunotherapy combination shows great promise for lung cancer, McMaster researchers find
McMaster University

Researchers at Canada's McMaster University have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than any other form of cancer.

Released: 19-Jan-2021 11:35 AM EST
National Research Effort Discovers Relationship Between Inflammation, Metabolism and Scleroderma Scarring
Michigan Medicine - University of Michigan

Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.

Released: 18-Jan-2021 2:00 PM EST
E-cigarettes Stress Lungs, Impair Protein Function
Pacific Northwest National Laboratory

E-cigarette exposure stresses and inflames the lungs of rats, compromising important quality control proteins, according to new research.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 14-Jan-2021 11:45 AM EST
Pulmonary Fibrosis Foundation Announces Sponsorship by United Therapeutics
Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) has announced United Therapeutics' sponsorship of the PFF Registry, a research resource that tracks clinical data, blood samples and patient-reported outcomes from individuals living with pulmonary fibrosis nationwide.

Released: 13-Jan-2021 2:30 PM EST
Is it Safe to Perform CPR During the COVID-19 Pandemic?
Michigan Medicine - University of Michigan

A new study analyzes the potential transmission risk of airborne respiratory pathogens during bystander-initiated cardiopulmonary resuscitation, or CPR.

Released: 13-Jan-2021 1:50 PM EST
Vaping Disrupts Blood, Air Flow Matching in Asymptomatic Users
American Physiological Society (APS)

There is more evidence that vaping causes abnormal lung function in young, otherwise healthy people.

Released: 13-Jan-2021 1:40 PM EST
Researchers receive DOD funding to expand study of investigational drug to prevent ARDS in COVID-19 patients
University of Texas Health Science Center at Houston

Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million in funding from the U.S. Department of Defense (DOD) to expand the Phase II clinical trial at UTHealth.

5-Jan-2021 11:45 AM EST
Wearable Electronics for Continuous Cardiac, Respiratory Monitoring
American Institute of Physics (AIP)

A small and inexpensive sensor, announced in Applied Physics Letters and based on an electrochemical system, could potentially be worn continuously by cardiac patients or others who require constant monitoring. A solution containing electrolyte substances is placed into a small circular cavity that is capped with a thin flexible diaphragm, allowing detection of subtle movements when placed on a patient’s chest. The authors suggest their sensor could be used for diagnosis of respiratory diseases.

   


close
2.48918